HUP0402639A2 - Szubsztituált akriloil-disztamicin-származékokat és protein kináz (szerin/treonin kináz) inhibitorokat tartalmazó tumorellenes kombinációs készítmény és alkalmazása - Google Patents
Szubsztituált akriloil-disztamicin-származékokat és protein kináz (szerin/treonin kináz) inhibitorokat tartalmazó tumorellenes kombinációs készítmény és alkalmazásaInfo
- Publication number
- HUP0402639A2 HUP0402639A2 HU0402639A HUP0402639A HUP0402639A2 HU P0402639 A2 HUP0402639 A2 HU P0402639A2 HU 0402639 A HU0402639 A HU 0402639A HU P0402639 A HUP0402639 A HU P0402639A HU P0402639 A2 HUP0402639 A2 HU P0402639A2
- Authority
- HU
- Hungary
- Prior art keywords
- serine
- inhibitors
- kinase
- distamycin derivatives
- protein kinase
- Prior art date
Links
- 102000001253 Protein Kinase Human genes 0.000 title abstract 2
- -1 acryloyl distamycin derivatives Chemical class 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 108060006633 protein kinase Chemical class 0.000 title abstract 2
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 title 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 abstract 1
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- UPBAOYRENQEPJO-UHFFFAOYSA-N n-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide Chemical class CN1C=C(NC=O)C=C1C(=O)NC1=CN(C)C(C(=O)NC2=CN(C)C(C(=O)NCCC(N)=N)=C2)=C1 UPBAOYRENQEPJO-UHFFFAOYSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
A találmány tárgya akriloil-disztamicin-származékok, különösen az (l)általános képletű a-bróm- és a-klór-akriloil-disztamicin-származékokés protein kináz (szerin/treonin és tirozin kináz) inhibitoralkalmazása tumorok kezelésére. Kiterjed a találmány a kombinációkalkalmazására tumor áttétek kezelésére vagy megelőzésére, és tumorokkezelésére az angiogenézis gátlásával. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02075052 | 2002-01-02 | ||
PCT/EP2002/013092 WO2003055522A1 (en) | 2002-01-02 | 2002-12-18 | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0402639A2 true HUP0402639A2 (hu) | 2005-04-28 |
HUP0402639A3 HUP0402639A3 (en) | 2012-02-28 |
Family
ID=8185508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0402639A HUP0402639A3 (en) | 2002-01-02 | 2002-12-18 | Antitumor combination comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors and its use |
Country Status (24)
Country | Link |
---|---|
US (1) | US20060084612A1 (hu) |
EP (1) | EP1461083B1 (hu) |
JP (1) | JP2005516025A (hu) |
KR (1) | KR20040078118A (hu) |
CN (1) | CN1617744A (hu) |
AT (1) | ATE321572T1 (hu) |
AU (1) | AU2002352090B8 (hu) |
BR (1) | BR0215454A (hu) |
CA (1) | CA2472008C (hu) |
CY (1) | CY1105269T1 (hu) |
DE (1) | DE60210329T2 (hu) |
DK (1) | DK1461083T3 (hu) |
ES (1) | ES2263835T3 (hu) |
HU (1) | HUP0402639A3 (hu) |
IL (2) | IL162820A0 (hu) |
MX (1) | MXPA04006543A (hu) |
NO (1) | NO20043217L (hu) |
NZ (1) | NZ533854A (hu) |
PL (1) | PL371179A1 (hu) |
PT (1) | PT1461083E (hu) |
RU (1) | RU2328306C2 (hu) |
SI (1) | SI1461083T1 (hu) |
WO (1) | WO2003055522A1 (hu) |
ZA (1) | ZA200405290B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003253350B2 (en) * | 2002-07-30 | 2008-06-26 | Aeterna Zentaris Gmbh | Use of alkyl phosphocholines in combination with antitumor medicaments |
US8383605B2 (en) | 2002-07-30 | 2013-02-26 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
PT1868599E (pt) * | 2005-04-08 | 2010-01-26 | Nerviano Medical Sciences Srl | Combinação anti-tumor, constituída por derivados substituídos de acriloil-distamicina e anticorpos que inibem os factores de crescimento ou os seus receptores |
CA2794513A1 (en) | 2010-03-31 | 2011-10-06 | Aeterna Zentaris Gmbh | Perifosine and capecitabine as a combined treatment for cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274576B1 (en) * | 1995-06-27 | 2001-08-14 | The Henry Jackson Foundation For The Advancement Of Military Medicine | Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
GB9615692D0 (en) * | 1996-07-25 | 1996-09-04 | Pharmacia Spa | Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
GB0015444D0 (en) * | 2000-06-23 | 2000-08-16 | Pharmacia & Upjohn Spa | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors |
GB0015447D0 (en) * | 2000-06-23 | 2000-08-16 | Pharmacia & Upjohn Spa | Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents |
-
2002
- 2002-12-18 BR BR0215454-4A patent/BR0215454A/pt not_active IP Right Cessation
- 2002-12-18 AU AU2002352090A patent/AU2002352090B8/en not_active Ceased
- 2002-12-18 ES ES02787763T patent/ES2263835T3/es not_active Expired - Lifetime
- 2002-12-18 KR KR10-2004-7010472A patent/KR20040078118A/ko not_active Application Discontinuation
- 2002-12-18 AT AT02787763T patent/ATE321572T1/de active
- 2002-12-18 MX MXPA04006543A patent/MXPA04006543A/es active IP Right Grant
- 2002-12-18 PL PL02371179A patent/PL371179A1/xx not_active Application Discontinuation
- 2002-12-18 WO PCT/EP2002/013092 patent/WO2003055522A1/en active IP Right Grant
- 2002-12-18 DK DK02787763T patent/DK1461083T3/da active
- 2002-12-18 EP EP02787763A patent/EP1461083B1/en not_active Expired - Lifetime
- 2002-12-18 CA CA002472008A patent/CA2472008C/en not_active Expired - Fee Related
- 2002-12-18 DE DE60210329T patent/DE60210329T2/de not_active Expired - Lifetime
- 2002-12-18 JP JP2003556098A patent/JP2005516025A/ja active Pending
- 2002-12-18 SI SI200230335T patent/SI1461083T1/sl unknown
- 2002-12-18 US US10/500,606 patent/US20060084612A1/en not_active Abandoned
- 2002-12-18 NZ NZ533854A patent/NZ533854A/en not_active IP Right Cessation
- 2002-12-18 PT PT02787763T patent/PT1461083E/pt unknown
- 2002-12-18 HU HU0402639A patent/HUP0402639A3/hu unknown
- 2002-12-18 IL IL16282002A patent/IL162820A0/xx unknown
- 2002-12-18 CN CNA028276744A patent/CN1617744A/zh active Pending
- 2002-12-18 RU RU2004123641/15A patent/RU2328306C2/ru not_active IP Right Cessation
-
2004
- 2004-07-01 IL IL162820A patent/IL162820A/en not_active IP Right Cessation
- 2004-07-02 ZA ZA200405290A patent/ZA200405290B/xx unknown
- 2004-07-29 NO NO20043217A patent/NO20043217L/no not_active Application Discontinuation
-
2006
- 2006-06-05 CY CY20061100717T patent/CY1105269T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2472008A1 (en) | 2003-07-10 |
AU2002352090B8 (en) | 2008-06-19 |
ES2263835T3 (es) | 2006-12-16 |
AU2002352090A1 (en) | 2003-07-15 |
PT1461083E (pt) | 2006-08-31 |
EP1461083B1 (en) | 2006-03-29 |
AU2002352090B2 (en) | 2008-05-15 |
PL371179A1 (en) | 2005-06-13 |
ZA200405290B (en) | 2005-06-17 |
MXPA04006543A (es) | 2004-10-04 |
IL162820A (en) | 2010-04-15 |
EP1461083A1 (en) | 2004-09-29 |
IL162820A0 (en) | 2005-11-20 |
SI1461083T1 (sl) | 2006-08-31 |
WO2003055522A1 (en) | 2003-07-10 |
DE60210329D1 (de) | 2006-05-18 |
DE60210329T2 (de) | 2006-11-30 |
RU2328306C2 (ru) | 2008-07-10 |
CY1105269T1 (el) | 2010-03-03 |
HUP0402639A3 (en) | 2012-02-28 |
CN1617744A (zh) | 2005-05-18 |
ATE321572T1 (de) | 2006-04-15 |
KR20040078118A (ko) | 2004-09-08 |
BR0215454A (pt) | 2004-11-23 |
RU2004123641A (ru) | 2005-06-10 |
DK1461083T3 (da) | 2006-07-10 |
US20060084612A1 (en) | 2006-04-20 |
JP2005516025A (ja) | 2005-06-02 |
NO20043217L (no) | 2004-07-30 |
CA2472008C (en) | 2009-07-28 |
NZ533854A (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60204553D1 (de) | Jun kinase inhibitoren | |
IL178675A0 (en) | Monocyclic heterocycles as kinase inhibitors | |
CY1117546T1 (el) | Eνωση διαμινο ετεροκυκλικου καρβοξαμιδιου | |
CL2008000020A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas sustituidas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y tumores malignos. | |
ATE554087T1 (de) | Neue kinaseinhibitoren | |
GEP20125368B (en) | Kinase inhibitors | |
RS85404A (en) | 4-(n-phenylamino)- quinazolines/quinolines as tyrosine kinase inhibitors | |
NO20060398L (no) | Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft | |
UA85087C2 (en) | Monocyclic heterocycles as kinase inhibitors | |
HUP0402639A2 (hu) | Szubsztituált akriloil-disztamicin-származékokat és protein kináz (szerin/treonin kináz) inhibitorokat tartalmazó tumorellenes kombinációs készítmény és alkalmazása | |
EA200300060A1 (ru) | Комбинированная противоопухолевая терапия, включающая применение производных замещенного акрилоилдистамицина и ингибиторов топоизомераз i и ii | |
DE502005010237D1 (de) | Stabile dosierungsform von phenylalanin-derivaten | |
DE50311665D1 (de) | Guanidinophenylalanin-verbindungen als urokinase-inhibitoren | |
TW200602023A (en) | Monocyclic heterocycles as kinase inhibitors | |
DK1261325T3 (da) | Tumorinhiberende sammensætninger, der indeholder nitroacridiner | |
WO2003004631A3 (en) | USE OF INHIBITORS OF EXPRESSION OR ACTIVITY OF p8/com1 FOR TREATING TUMORS. | |
UA101464C2 (en) | Phosphatidylinositol 3-kinase inhibitors and methods of their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: NERVIANO MEDICAL SCIENCES S.R.L., IT Free format text: FORMER OWNER(S): PHARMACIA ITALIA S.P.A., IT |
|
FD9A | Lapse of provisional protection due to non-payment of fees |